| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5994348 | SANOFI AVENTIS US | Pharmaceutical compositions containing irbesartan |
Jun, 2015
(8 years ago) | |
|
US5994348 (Pediatric) | SANOFI AVENTIS US | Pharmaceutical compositions containing irbesartan |
Dec, 2015
(8 years ago) | |
Avalide is owned by Sanofi Aventis Us.
Avalide contains Hydrochlorothiazide; Irbesartan.
Avalide has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Avalide are:
- US5994348
- US5994348*PED
Avalide was authorised for market use on 30 September, 1997.
Avalide is available in tablet;oral dosage forms.
The generics of Avalide are possible to be released after 07 December, 2015.
Drugs and Companies using HYDROCHLOROTHIAZIDE; IRBESARTAN ingredient
Market Authorisation Date: 30 September, 1997
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of AVALIDE before it's drug patent expiration?
More Information on Dosage
AVALIDE family patents
